DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kim JY, You CW.
The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A.
Blood Res 2019;
54 (03) 204-209
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.